Results 151 to 160 of about 205,440 (310)

Synbiotic intervention reverses alcohol drinking-induced cognitive deficits in adolescent male mice by modulating the microbiota-gut-brain axis. [PDF]

open access: yesGut Microbes
Barrera-Conde M   +10 more
europepmc   +1 more source

ALCOHOL DRINKING AND GALLSTONE DISEASE

open access: bronze, 1995
Carel Thijs   +2 more
openalex   +1 more source

Phenylenediamine‐Derived Carbon Dots for Carbon‐Based Supercapacitors

open access: yesBatteries &Supercaps, EarlyView.
This study, phenylenediamine‐derived fluorescent carbon dots are directly used as active electrode materials in carbon‐based supercapacitors in both symmetric and asymmetric configurations without the need for hybridization and their electrochemical performances are evaluated to explore their potential.
Melis Ozge Alas Colak   +4 more
wiley   +1 more source

Genotype‐dependent variation in buffering capacity and pH stability of sugarcane juice during fermentation

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract Buffering capacity (BC) is essential for maintaining pH stability during fermentation, directly impacting yeast performance, aroma formation, and final beverage quality. This study evaluated the BC and pH dynamics of sugarcane juice from 10 genotypes before and after fermentation to identify traits associated with juice stability.
Maria Clara De‐Barros   +1 more
wiley   +1 more source

Alcohol drinking leads to sex-dependent differentiation of T cells. [PDF]

open access: yesEur J Trauma Emerg Surg
Sturm R   +4 more
europepmc   +1 more source

Quantitative Autoradiography of Mu‐Opioid Receptors in the CNS of High–Alcohol‐Drinking (HAD) and Low–Alcohol‐Drinking (LAD) Rats [PDF]

open access: bronze, 2001
Jennifer E. Learn   +4 more
openalex   +1 more source

Pharmacokinetics, pharmacodynamics and safety of casdatifan, a novel hypoxia‐inducible factor‐2α inhibitor, in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Casdatifan is an orally bioavailable small‐molecule hypoxia‐inducible factor‐2α (HIF‐2α) inhibitor currently in development for treating patients with clear cell renal cell carcinomas. The aim of this study was to characterize the pharmacokinetics (PK), pharmacodynamics and safety of casdatifan in healthy participants.
Mohammad Ghasemi   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy